How to use medicines in children: Principles of paediatric clinical pharmacology

Authors

  • Yashwant Sinha,

    Corresponding author
    1. Prince of Wales Hospital, Randwick,
    2. The Children’s Hospital at Westmead, New South Wales and
      Dr Yashwant Sinha, Centre for Kidney Research, The Children’s Hospital at Westmead, Locked Bag 4001, Westmead 2145, Australia. Fax: +61 2 9845 1491, email: yashwans@chw.edu.au
    Search for more papers by this author
  • Noel E Cranswick

    1. Department of Clinical Pharmacology, Royal Children’s Hospital, Parkville, Victoria, Australia
    Search for more papers by this author

Dr Yashwant Sinha, Centre for Kidney Research, The Children’s Hospital at Westmead, Locked Bag 4001, Westmead 2145, Australia. Fax: +61 2 9845 1491, email: yashwans@chw.edu.au

Abstract

Abstract:  Knowledge of drug administration in children and infants has significantly lagged behind that of adults. Despite several paediatric therapeutic mishaps that have been a catalyst for major regulatory reform, the majority of registered medicines do not have indications or dosing for children. This paper will briefly summarise key issues in paediatric pharmacology, including differences in prescribing for children, off-label and unlicensed prescribing and conduct of paediatric clinical trials. A particular emphasis will placed on the situation in Australia.

Ancillary